Shareholders that Lost Money on Regeneron Pharmaceuticals, Inc. (REGN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=123950&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com […]